Issued Patents All Time
Showing 26–50 of 58 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 7592324 | RNAi-mediated inhibition of ocular targets | Allan R. Shepard, Jon E. Chatterton, Martin B. Wax | 2009-09-22 |
| 7405192 | Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma | Robert J. Wordinger | 2008-07-29 |
| 7384926 | Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma | Iok-Hou Pang | 2008-06-10 |
| 7357931 | Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents | Wan-Heng Wang, Loretta McNatt | 2008-04-15 |
| 7351407 | Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies | Debra L. Fleenor, Allan R. Shepard, Nasreen Jacobson, Iok-Hou Pang | 2008-04-01 |
| 7220546 | Methods for diagnosing glaucoma and discovering anti-glaucoma drugs | Robert J. Wordinger | 2007-05-22 |
| 7033755 | Diagnostics and therapeutics for glaucoma | John Fingert, Loretta McNatt, Edwin M. Stone, Wan-Heng Wang | 2006-04-25 |
| 7005446 | Use of AP-1 activators to treat glaucoma and ocular hypertension | Debra Shade, Iok-Hou Pang | 2006-02-28 |
| 6534475 | Use of TIMP-3 inducers of TIMP-3 expression, and TIMP-3 mimetics to treat ocular neovascularization | — | 2003-03-18 |
| 6444676 | Use of PARP inhibitors in the treatment of glaucoma | Iok-Hou Pang | 2002-09-03 |
| 6413245 | Sub-tenon drug delivery | Yoseph Yaacobi, David C. Dahlin, Craig B. Struble, David A. Marsh, Billie M. York, Jr. | 2002-07-02 |
| 6297228 | Use of angiostatic steroids in photodynamic therapy | — | 2001-10-02 |
| 6177427 | Treatment of glaucoma and ocular hypertension | Raymond E. Conrow | 2001-01-23 |
| 6172054 | Combination therapy for lowering and controlling intraocular pressure | — | 2001-01-09 |
| 6090798 | Treatment of GLC1A glaucoma with glucocorticoid antagonists | — | 2000-07-18 |
| 6071875 | TGF.alpha. for the treatment of ocular hypertension and glaucoma | Robert J. Wordinger | 2000-06-06 |
| 6051573 | Treatment of GLC1A glaucoma with non-steroidal glucocorticoid antagonists | — | 2000-04-18 |
| 6011023 | Angiostatic steroids | Raymond E. Conrow | 2000-01-04 |
| 5990099 | Angiostatic agents and methods and compositions for controlling ocular hypertension | — | 1999-11-23 |
| 5929111 | A-seco steroids effective at treating ophthalmic pathological neovascularization and controlling intraocular pressure | Raymond E. Conrow | 1999-07-27 |
| 5770592 | Prevention and treatment of ocular neovascularization using angiostatic steroids | — | 1998-06-23 |
| 5700794 | Treatment of ocular hypotony | — | 1997-12-23 |
| 5698545 | Angiostatic steroids and methods and compositions for controlling ocular hypertension | Raymond E. Conrow | 1997-12-16 |
| 5686621 | Substituted hydrindanes for the treatment of angiogenesis-dependent diseases | Raymond E. Conrow | 1997-11-11 |
| 5686407 | Hepatocyte growth factor to treat glaucoma | Robert J. Wordinger | 1997-11-11 |